CEO of Cell Therapeutics Inc. (CTIC) James A Bianco sells 100,000 shares of CTIC on 11/05/2010 at an average price of $0.39 a share.

Cell Therapeutics Inc. has a market cap of $304.6 million; its shares were traded at around $0.385 with and P/S ratio of 3808.

CTIC is in the portfolios of Steven Cohen of SAC Capital Advisors.

This is the annual revenues and earnings per share of CTIC over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of CTIC.

CEO Recent Trades:

• Sell: CEO James A Bianco sold 400,000 shares of CTIC stock on 09/30/2010 at the average price of 0.38. James A Bianco owns at least 13,022,660 shares after this. The price of the stock has increased by 1.32% since.


• Sell: CEO James A Bianco sold 250,000 shares of CTIC stock on 08/10/2010 at the average price of 0.4. James A Bianco owns at least 13,422,660 shares after this. The price of the stock has decreased by 3.75% since.


• Sell: CEO James A Bianco sold 500,000 shares of CTIC stock on 06/30/2010 at the average price of 0.37. James A Bianco owns at least 3,706,050 shares after this. The price of the stock has increased by 4.05% since.

This is the insider trade history vs. stock price of CTIC. For the complete insider trading history of CTIC, click here.

Directors and Officers Recent Trades:

• Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 10/29/2010 at the average price of 0.38. Phillip M Phd Nudelman owns at least 2,394,865 shares after this. The price of the stock has increased by 1.32% since.


• Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 09/30/2010 at the average price of 0.38. Phillip M Phd Nudelman owns at least 2,434,865 shares after this. The price of the stock has increased by 1.32% since.


• Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 08/31/2010 at the average price of 0.36. Phillip M Phd Nudelman owns at least 2,454,865 shares after this. The price of the stock has increased by 6.94% since.


• Sell: Director Richard L Love sold 75,000 shares of CTIC stock on 08/23/2010 at the average price of 0.37. Richard L Love owns at least 2,357,773 shares after this. The price of the stock has increased by 4.05% since.


• Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 07/30/2010 at the average price of 0.4. Phillip M Phd Nudelman owns at least 2,494,865 shares after this. The price of the stock has decreased by 3.75% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool